These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38303194)

  • 1. [A Case of Rectal Cancer That Could Be Safely Resected by Laparoscopic Surgery, after Capecitabine plus L-OHP plus Cetuximab as Pre-Operative Chemotherapy].
    Fukuda Y; Otsubo I; Miyazaki H; Kikuchi T; Kusano S; Mizuta N; Ashitani H; Tsunemi K; Toyokawa A
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1747-1749. PubMed ID: 38303194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Pathological Complete Response after Neoadjuvant Chemotherapy(S-1 plus Oxaliplatin)and Laparoscopic Low Anterior Resection for Rectal Cancer].
    Ichinohe D; Morohashi H; Umetsu S; Yoshida T; Wakasa Y; Odagiri T; Kimura T; Suto A; Saito T; Yoshida E; Akasaka H; Jin H; Miura T; Sakamoto Y; Hakamada K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1715-1717. PubMed ID: 28133108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Conversion Surgery after Chemotherapy for Locally Advanced Unresectable Rectal Cancer].
    Kawabe Y; Inoue A; Kagawa Y; Nishizawa Y; Ozato Y; Hayashi N; Shindo M; Suzuki K; Komatsu H; Hirota M; Miyazaki Y; Tomokuni A; Motoori M; Iwase K; Fujitani K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1768-1770. PubMed ID: 38303201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two Cases of Locally Advanced Lower Rectal Cancer with Pathological Complete Response after Cetuximab plus SOX as Neoadjuvant Chemotherapy].
    Tokuhara K; Satake R; Ueyama Y; Yamamichi K; Sekimoto M
    Gan To Kagaku Ryoho; 2021 Nov; 48(11):1405-1407. PubMed ID: 34795136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer.
    Bazarbashi S; Omar A; Aljubran A; Alzahrani A; Alsanea N; Abduljabbar A; Alhomoud S; Ashari L; Balaraj K; Soudy H; Neimatallah M; Fagih M
    Hematol Oncol Stem Cell Ther; 2016 Dec; 9(4):147-153. PubMed ID: 27613373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
    Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
    J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Pathological CR in Local Advanced Rectal Cancer Treated with Laparoscopic ISR after XELOXIRI Chemotherapy].
    Kawai K; Murata K; Hata T; Kagawa Y; Naito A; Sakamoto T; Murakami K; Katsura Y; Omura Y; Masuzawa T; Takeno A; Takeda Y
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2096-2097. PubMed ID: 32157071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Resected Case of Advanced Lower Rectal Cancer with Neoadjuvant Chemotherapy by FOLFOXIRI plus Cetuximab].
    Yamada K; Ioka T; Suzuki N; Yoshida S; Tomochika S; Matsukuma S; Matsui H; Shindo Y; Tokumitsu Y; Watanabe Y; Iida M; Takeda S; Hazama S; Ueno T; Nagano H
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2067-2069. PubMed ID: 35045495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Postoperative Recurrence of Rectal Cancer in Which Desensitization Therapy Was Effective against Oxaliplatin Allergy in L-OHP].
    Katagiri M; Miwa K; Shimomura S; Yomoda T; Tajiri K; Nagasu S; Fujino S; Koushi K; Fujita F; Kinugasa T; Akagi Y
    Gan To Kagaku Ryoho; 2018 May; 45(5):875-878. PubMed ID: 30026456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Advanced Rectal Cancer with Synchronous Pulmonary Metastasis Undergoing Laparoscopic Curative Resection after Chemotherapy].
    Okano M; Okuyama M; Hata T; Ogino T; Kawada J; Kim Y; Tsujinaka T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1376-1378. PubMed ID: 29394639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term outcomes of neoadjuvant chemotherapy with capecitabine plus oxaliplatin for patients with locally advanced rectal cancer followed by total or tumor-specific mesorectal excision with or without lateral pelvic lymph node dissection.
    Sakamoto W; Kanke Y; Onozawa H; Okayama H; Endo H; Fujita S; Saito M; Saze Z; Momma T; Kono K
    Fukushima J Med Sci; 2022 Aug; 68(2):89-95. PubMed ID: 35732415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II).
    Hattori N; Nakayama G; Uehara K; Aiba T; Ishigure K; Sakamoto E; Tojima Y; Kanda M; Kobayashi D; Tanaka C; Yamada S; Koike M; Fujiwara M; Nagino M; Kodera Y
    Int J Clin Oncol; 2020 Jan; 25(1):118-125. PubMed ID: 31542847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study.
    Sun PL; Li B; Ye QF
    Int J Colorectal Dis; 2012 Oct; 27(10):1325-32. PubMed ID: 22430888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of an Unresectable Locally Advanced Rectal Cancer with Surrounding Organ Invasion Successfully Resected after Chemotherapy with mFOLFOX6 plus Cetuximab].
    Takagi H; Ariake K; Takemura S; Doi T
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):377-9. PubMed ID: 27067860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.
    Horisberger K; Treschl A; Mai S; Barreto-Miranda M; Kienle P; Ströbel P; Erben P; Woernle C; Dinter D; Kähler G; Hochhaus A; Post S; Willeke F; Wenz F; Hofheinz RD;
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1487-93. PubMed ID: 19131187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
    Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case Report on a Successful Resection after FOLFIRI plus Cetuximab Therapy for Unresectable Colorectal Cancer with Multiple Liver Metastases].
    Kanamori M; Kurumiya Y; Mizuno K; Sekoguchi E; Kobayashi S; Fukami Y; Kiriyama M; Aoyama H; Oiwa T; Miyamura K; Jinno T; Nakashima Y; Mori M
    Gan To Kagaku Ryoho; 2017 May; 44(5):417-420. PubMed ID: 28536339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.
    Mizushima T; Ikeda M; Kato T; Ikeda A; Nishimura J; Hata T; Matsuda C; Satoh T; Mori M; Doki Y
    BMC Cancer; 2019 Sep; 19(1):929. PubMed ID: 31533662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).
    Ricardi U; Racca P; Franco P; Munoz F; Fanchini L; Rondi N; Dongiovanni V; Gabriele P; Cassoni P; Ciuffreda L; Morino M; Filippi AR; Aglietta M; Bertetto O
    Med Oncol; 2013; 30(2):581. PubMed ID: 23606239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
    Souglakos J; Kalykaki A; Vamvakas L; Androulakis N; Kalbakis K; Agelaki S; Vardakis N; Tzardi M; Kotsakis AP; Gioulbasanis J; Tsetis D; Sfakiotaki G; Chatzidaki D; Mavroudis D; Georgoulias V
    Ann Oncol; 2007 Feb; 18(2):305-10. PubMed ID: 17079693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.